Trends in Synthetic and Recombinant Bone Morphogenetic Proteins
Post-COVID Market Recovery and BMP Utilization Trends
The COVID-19 pandemic disrupted surgical procedures worldwide, slowing growth in the Bone Morphogenetic Protein Market. However, recovery is now underway, with elective surgeries resuming and hospitals investing in efficiency-boosting innovations like BMPs.
Post-pandemic, there’s a stronger focus on minimally invasive and outpatient procedures, which aligns well with BMP-enhanced treatments that reduce recovery times. Hospitals are also more inclined to adopt biologics that lower the need for secondary interventions.
2 visualizações